Germany
Japan
United Kingdom
China
Antibodies
View as table Download
Rabbit polyclonal Trk B (Ab-515) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human Trk B around the phosphorylation site of tyrosine 515 (P-Q-YP-F-G). |
| Modifications | Phospho-specific |
Rabbit polyclonal CD227/MUC1 (Tyr1229) antibody(Phospho-specific)
| Applications | IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human CD227/MUC1 around the phosphorylation site of tyrosine 1229 (S-P-YP-E-K) |
| Modifications | Phospho-specific |
Rabbit polyclonal IRS-1 (Ser307) antibody(Phospho-specific)
| Applications | IF, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human IRS-1 around the phosphorylation site of serine 307 (T-E-SP-I-T). |
| Modifications | Phospho-specific |
Rabbit polyclonal eIF4B (Ser422) antibody(Phospho-specific)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human eIF4B around the phosphorylation site of serine 422 (T-G-SP-E-S). |
| Modifications | Phospho-specific |
Rabbit polyclonal Cyclin D3 (Thr283) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Cyclin D3 around the phosphorylation site of threonine 283 (T-S-TP-P-T). |
| Modifications | Phospho-specific |
Rabbit polyclonal Dynamin-1 (Ser774) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human DYN1 around the phosphorylation site of serine 774 (R-R-SP-P-T). |
| Modifications | Phospho-specific |
Rabbit polyclonal hnRPD (Ser83) antibody(Phospho-specific)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human hnRPD around the phosphorylation site of serine 83 (N-S-SP-P-R). |
| Modifications | Phospho-specific |
Rabbit polyclonal IGF2R (Ser2409) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human IGF2R around the phosphorylation site of serine 2409 (Q-D-SP-E-D). |
| Modifications | Phospho-specific |
Rabbit polyclonal PKA alpha/beta CAT (Thr197) antibody(Phospho-specific)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human PKA a/β CAT around the phosphorylation site of threonine 197 (T-W-TP-L-C). |
| Modifications | Phospho-specific |
Rabbit polyclonal 14-3-3 zeta (Ser58) antibody(Phospho-specific)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human 14-3-3 ? around the phosphorylation site of serine 58 (R-S-SP-W-R) |
| Modifications | Phospho-specific |
Rabbit polyclonal SF1 (Ser82) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human SF1 around the phosphorylation site of serine 82 (S-P-SP-P-E). |
| Modifications | Phospho-specific |
Rabbit polyclonal PEA-15 (Ser104) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human PEA-15 around the phosphorylation site of serine 104(I-P-SP-A-K). |
| Modifications | Phospho-specific |
Rabbit polyclonal Rho/Rac Guanine Nucleotide Exchange Factor 2 (Ser885) antibody(Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Rho/Rac Guanine Nucleotide Exchange Factor 2 around the phosphorylation site of serine 885 (R-R-SP-L-P). |
| Modifications | Phospho-specific |
Rabbit polyclonal ETS1 (Thr38) antibody(Phospho-specific)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human ETS1 around the phosphorylation site of threonine 38 (L-L-TP-P-S). |
| Modifications | Phospho-specific |
Rabbit polyclonal PDCD4(Ser67) antibody(Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human PDCD4 around the phosphorylation site of serine 67 (K-N-SP-S-R). |
| Modifications | Phospho-specific |
Rabbit Polyclonal AhR (Ser36) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human AhR around the phosphorylation site of Serine 36 |
| Modifications | Phospho-specific |
Rabbit Polyclonal Akt (Thr308) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human Akt around the phosphorylation site of Threonine 308 |
| Modifications | Phospho-specific |
Rabbit Polyclonal CaMK2- beta/ gamma/ delta (Thr287) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human CaMK2- beta/ gamma/ delta around the phosphorylation site of Threonine 287 |
| Modifications | Phospho-specific |
Rabbit Polyclonal Caspase 9 (Thr125) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human Caspase 9 around the phosphorylation site of Threonine 125 |
| Modifications | Phospho-specific |
Rabbit Polyclonal C/EBP- beta (Thr235/188) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human C/EBP- beta around the phosphorylation site of Threonine 235/188 |
| Modifications | Phospho-specific |
Rabbit Polyclonal CHOP (Ser30) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human CHOP around the phosphorylation site of Serine 30 |
| Modifications | Phospho-specific |
Rabbit Polyclonal MAP3K7 (Thr187) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human MAP3K7 around the phosphorylation site of Threonine 187 |
| Modifications | Phospho-specific |
Rabbit Polyclonal NFAT4 (Ser165) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human NFAT4 around the phosphorylation site of Serine 165 |
| Modifications | Phospho-specific |
Rabbit Polyclonal NF- kappaB p65 (Ser536) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human NF- kappaB p65 around the phosphorylation site of Serine 536 |
| Modifications | Phospho-specific |
Rabbit Polyclonal AML1 (Ser276) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human AML1 around the phosphorylation site of Serine 276 |
| Modifications | Phospho-specific |
Rabbit Polyclonal AML1 (Ser303) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human AML1 around the phosphorylation site of Serine 303 |
| Modifications | Phospho-specific |
Rabbit Polyclonal Synuclein (Ser129) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human Synuclein around the phosphorylation site of Serine 129 |
| Modifications | Phospho-specific |
Rabbit Polyclonal Src (Tyr418) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human Src around the phosphorylation site of Tyrosine 418 |
| Modifications | Phospho-specific |
Rabbit Polyclonal Src (Tyr529) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human Src around the phosphorylation site of Tyrosine 529 |
| Modifications | Phospho-specific |
Rabbit Polyclonal XIAP (Ser87) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human XIAP around the phosphorylation site of Serine 87 |
| Modifications | Phospho-specific |
Rabbit polyclonal c-Jun (Phospho-Ser63) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human c-Jun around the phosphorylation site of Serine 63. |
| Modifications | Phospho-specific |
Rabbit polyclonal ATF-4 (Phospho-Ser219) antibody
| Applications | WB |
| Reactivities | H:S219, M:S218 |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human ATF-4. |
| Modifications | Phospho-specific |
Rabbit polyclonal Amyloid β A4 (Phospho-Thr743/668) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Amyloid β A4 around the phosphorylation site of threonine 743 (A-V-TP-P-E) |
| Modifications | Phospho-specific |
Rabbit polyclonal B-RAF (Phospho-Ser446) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human B-RAF around the phosphorylation site of serine 446 (R-D-SP-S-D). |
| Modifications | Phospho-specific |
Rabbit polyclonal NPM (Phospho-Thr199) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human NPM around the phosphorylation site of threonine 199 (R-D-TP-P-A). |
| Modifications | Phospho-specific |
Rabbit polyclonal Ezrin (Phospho-Tyr478) antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Ezrin around the phosphorylation site of tyrosine 478 (P-V-YP-E-P) |
| Modifications | Phospho-specific |
Rabbit Anti-14-3-3 (Ser58) Antibody (Phospho-Specific)
| Applications | WB |
| Reactivities | Human, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic phospho-peptide corresponding to amino acid residues surrounding Ser58 conjugated to KLH |
| Modifications | Phospho-specific |
Rabbit Anti-MeCP2 (Ser80) Antibody (Phospho-Specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic phospho-peptide corresponding to amino acid residues surrounding Ser80 conjugated to KLH |
| Modifications | Phospho-specific |
Rabbit anti-NF2 (Merlin, Phospho-Ser518) polyclonal antibody(Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanMerlin around the phosphorylation site of serine 518 (R-L-SP-M-E). |
| Modifications | Phospho-specific |
Rabbit polyclonal STAT5B (Ser731) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human STAT5B around the phosphorylation site of serine 731 (A-P-SP-P-A). |
| Modifications | Phospho-specific |
Rabbit polyclonal Estrogen Receptor-a (Tyr537) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human ER-a around the phosphorylation site of tyrosine 537 (P-L-YP-D-L). |
| Modifications | Phospho-specific |
Rabbit polyclonal c-Met (Ab-1003) antibody
| Applications | IF, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human c-Met around the phosphorylation site of tyrosine 1003 (V-D-YP-R-A). |
| Modifications | Phospho-specific |
Rabbit polyclonal p47 phox/NCF1 (Ab-345) antibody
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human p47 phox around the phosphorylation site of serine 345 (P-Q-SP-P-G). |
| Modifications | Phospho-specific |
Rabbit polyclonal NCF1/Neutrophil Cytosol Factor 1 (Ser304)(Phospho-specific)
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Neutrophil Cytosol Factor 1 around the phosphorylation site of serine 304 (R-S-SP-I-R). |
| Modifications | Phospho-specific |
Rabbit polyclonal p47 phox/NCF1 (Ab-359) antibody
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human p47 phox around the phosphorylation site of serine 359 (Q-R-SP-K-P). |
| Modifications | Phospho-specific |
Rabbit polyclonal CD44 (Ser706) antibody(Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human CD44 around the phosphorylation site of serine 706 (S-K-SP-Q-E). |
| Modifications | Phospho-specific |
Rabbit polyclonal IGF1R (Ab-1346) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human IGF1R around the phosphorylation site of tyrosine 1346 (Q-P-YP-A-H). |
| Modifications | Phospho-specific |
Active filters
Category
-
Antibodies
- Primary Antibodies
Applications
- WB
Clonalities
- Polyclonal
Modifications
- Phospho-specific
Availabilities
- In Stock
Filter by
Target Symbol
- EGFR (13)
- MAPT (12)
- JUN (9)
- AKT1 (7)
- TP53 (7)
- CHEK1 (6)
- EZR (6)
- MET (6)
- NFKB1 (6)
- RELA (6)
- ABL1 (5)
- ESR1 (5)
- FGFR1 (5)
- FOXO1 (5)
- GRIN2B (5)
- IRS1 (5)
- MAPK14 (5)
- NR3C1 (5)
- PTK2 (5)
- RAF1 (5)
- RPS6KB1 (5)
- SMAD3 (5)
- TH (5)
- ATF2 (4)
- CHEK2 (4)
- CHUK (4)
- CREB1 (4)
- CSF1R (4)
- CTNNB1 (4)
- ERBB2 (4)
- IGF1R (4)
- JAK2 (4)
- MAPK3 (4)
- NOS3 (4)
- PDCD4 (4)
- PRKCD (4)
- SRC (4)
- STAT1 (4)
- STAT3 (4)
- STAT5A (4)
- BCL2 (3)
- BRAF (3)
- CAMK2A (3)
- CCND3 (3)
- CDC25A (3)
- CDK2 (3)
- CDKN1B (3)
- CEBPA (3)
- DNM1 (3)
- EIF4EBP1 (3)
- FRS2 (3)
- GAB2 (3)
- GSK3A (3)
- IKBKG (3)
- IRF3 (3)
- KDR (3)
- MAP2K1 (3)
- MAPK8 (3)
- MTOR (3)
- NCF1 (3)
- PAK1 (3)
- PDGFRB (3)
- PPP1R1B (3)
- PXN (3)
- RB1 (3)
- RPS6KA5 (3)
- RUNX1 (3)
- SHC1 (3)
- SMAD1 (3)
- SNCA (3)
- STMN1 (3)
- SYK (3)
- SYT1 (3)
- YWHAZ (3)
- ACACA (2)
- ADD1 (2)
- AHR (2)
- ALK (2)
- APP (2)
- ATP1A1 (2)
- ATRIP (2)
- BAD (2)
- BCAR1 (2)
- BCL2L1 (2)
- BIK (2)
- BLNK (2)
- CAMK2B (2)
- CASP8 (2)
- CASP9 (2)
- CCNB1 (2)
- CCNE1 (2)
- CCR5 (2)
- CD44 (2)
- CDC25B (2)
- CFL1 (2)
- CTTN (2)
- CYP2B6 (2)
- DPYSL2 (2)
- EFNA2 (2)
- EPHA2 (2)
Reactivities
Antibody Hosts
Conjugates
Families
- Druggable Genome (571)
- Protein Kinase (198)
- Transcription Factors (180)
- ES Cell Differentiation/IPS (115)
- Transmembrane (115)
- Stem cell - Pluripotency (60)
- Stem cell relevant signaling - JAK/STAT signaling pathway (37)
- Adult stem cells (24)
- Secreted Protein (24)
- Cancer stem cells (23)
- Nuclear Hormone Receptor (18)
- Embryonic stem cells (13)
- Phosphatase (13)
- GPCR (10)
- Stem cell relevant signaling - DSL/Notch pathway (10)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (9)
- Protease (7)
- Ion Channels: Glutamate Receptors (6)
- Induced pluripotent stem cells (3)
- P450 (2)
- Stem cell relevant signaling - Wnt Signaling pathway (2)
- Ion Channels: Cys-loop Receptors (1)
- Ion Channels: Other (1)
- Ion Channels: Potassium (1)
Pathways
- Pathways in cancer (217)
- MAPK signaling pathway (156)
- Prostate cancer (129)
- Focal adhesion (127)
- Neurotrophin signaling pathway (125)
- ErbB signaling pathway (119)
- Chronic myeloid leukemia (104)
- Chemokine signaling pathway (103)
- Pancreatic cancer (98)
- Colorectal cancer (91)
- T cell receptor signaling pathway (85)
- Acute myeloid leukemia (82)
- Glioma (81)
- Regulation of actin cytoskeleton (80)
- Insulin signaling pathway (79)
- Epithelial cell signaling in Helicobacter pylori infection (77)
- Melanoma (77)
- Toll-like receptor signaling pathway (75)
- B cell receptor signaling pathway (74)
- GnRH signaling pathway (74)
- Small cell lung cancer (73)
- Non-small cell lung cancer (68)
- Fc gamma R-mediated phagocytosis (66)
- Adherens junction (64)
- Endometrial cancer (64)
- Cell cycle (63)
- VEGF signaling pathway (63)
- Fc epsilon RI signaling pathway (59)
- Adipocytokine signaling pathway (58)
- Apoptosis (54)
- Progesterone-mediated oocyte maturation (54)
- Bladder cancer (53)
- Endocytosis (53)
- Leukocyte transendothelial migration (50)
- Renal cell carcinoma (48)
- Wnt signaling pathway (48)
- Natural killer cell mediated cytotoxicity (47)
- Jak-STAT signaling pathway (46)
- Calcium signaling pathway (44)
- Alzheimer's disease (43)
- Axon guidance (43)
- Gap junction (43)
- NOD-like receptor signaling pathway (43)
- Cytokine-cytokine receptor interaction (41)
- RIG-I-like receptor signaling pathway (41)
- p53 signaling pathway (41)
- Long-term potentiation (37)
- Oocyte meiosis (37)
- Tight junction (37)
- Amyotrophic lateral sclerosis (ALS) (36)
- Melanogenesis (36)
- Pathogenic Escherichia coli infection (34)
- mTOR signaling pathway (34)
- Long-term depression (31)
- Vascular smooth muscle contraction (30)
- Metabolic pathways (29)
- Cytosolic DNA-sensing pathway (27)
- Thyroid cancer (26)
- Type II diabetes mellitus (26)
- Huntington's disease (25)
- Dorso-ventral axis formation (22)
- TGF-beta signaling pathway (22)
- Neuroactive ligand-receptor interaction (18)
- Viral myocarditis (17)
- Hematopoietic cell lineage (15)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (13)
- Hypertrophic cardiomyopathy (HCM) (12)
- Prion diseases (12)
- Basal cell carcinoma (11)
- Dilated cardiomyopathy (11)
- Parkinson's disease (11)
- Vibrio cholerae infection (10)
- Primary immunodeficiency (9)
- Phosphatidylinositol signaling system (8)
- Systemic lupus erythematosus (8)
- Cell adhesion molecules (CAMs) (7)
- Olfactory transduction (7)
- ECM-receptor interaction (6)
- Ubiquitin mediated proteolysis (6)
- Antigen processing and presentation (5)
- Arginine and proline metabolism (5)
- Tyrosine metabolism (5)
- Arachidonic acid metabolism (4)
- Homologous recombination (4)
- Inositol phosphate metabolism (4)
- Cardiac muscle contraction (3)
- Notch signaling pathway (3)
- Complement and coagulation cascades (2)
- Drug metabolism - cytochrome P450 (2)
- Fatty acid biosynthesis (2)
- Hedgehog signaling pathway (2)
- Maturity onset diabetes of the young (2)
- Metabolism of xenobiotics by cytochrome P450 (2)
- Nucleotide excision repair (2)
- Propanoate metabolism (2)
- Pyruvate metabolism (2)
- Retinol metabolism (2)
- Ribosome (2)
- SNARE interactions in vesicular transport (2)
- Spliceosome (2)
- Taste transduction (2)
- Alanine (1)
- Butanoate metabolism (1)
- DNA replication (1)
- Drug metabolism - other enzymes (1)
- Ether lipid metabolism (1)
- Folate biosynthesis (1)
- Glycerophospholipid metabolism (1)
- Linoleic acid metabolism (1)
- Lysosome (1)
- Mismatch repair (1)
- PPAR signaling pathway (1)
- Pyrimidine metabolism (1)
- Regulation of autophagy (1)
- Starch and sucrose metabolism (1)
- Taurine and hypotaurine metabolism (1)
- Tryptophan metabolism (1)
- Type I diabetes mellitus (1)
- alpha-Linolenic acid metabolism (1)
- aspartate and glutamate metabolism (1)
- beta-Alanine metabolism (1)